4//SEC Filing
John Anish M. 4
Accession 0001493152-22-023381
CIK 0001642380other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:19 PM ET
Size
7.4 KB
Accession
0001493152-22-023381
Insider Transaction Report
Form 4
John Anish M.
SVP, Finance, and Interim CFO
Transactions
- Award
Common Stock, no par value
2022-08-15+150,000→ 150,000 total - Award
Option to Purchase Common Stock
2022-08-15+100,000→ 100,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.
- [F2]25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001933248
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 8:19 PM ET
- Size
- 7.4 KB